Danazol for Genetic Bone Marrow and Lung Disorders
Clinical trial NCT01441037 · COMPLETED
Trial details
- NCT number
- NCT01441037
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-19
- Primary completion
- 2016-11-14
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.